Bgm (BGM) Property, Plant & Equipment (Net) (2019 - 2025)
Bgm (BGM) Property, Plant & Equipment (Net) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 2.55 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.93 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.76 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 13.44 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.93 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.44 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 90.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.41 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Bgm | 30.61 Mn | 20.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 644,854.00 |
| Mar 31, 2025 | 644,854.00 |
| Sep 30, 2024 | 660,569.00 |
| Sep 30, 2024 | 660,569.00 |
| Mar 31, 2024 | 641,014.00 |
| Mar 31, 2024 | 641,014.00 |
| Sep 30, 2023 | 295,298.00 |
| Sep 30, 2023 | 295,298.00 |
| Mar 31, 2023 | 10,720.41 Bn |
| Mar 31, 2023 | 10,720.41 Bn |
| Sep 30, 2022 | 10,184.03 Bn |
| Sep 30, 2022 | 10,184.03 Bn |
| Mar 31, 2022 | 10,677.35 Bn |
| Mar 31, 2022 | 10,677.35 Bn |
| Sep 30, 2021 | 9.12 Mn |
| Sep 30, 2021 | 9.12 Mn |
| Mar 31, 2021 | 8,189.52 Bn |
| Mar 31, 2021 | 8,189.52 Bn |
| Sep 30, 2020 | 7.42 Mn |
| Sep 30, 2020 | 7.42 Mn |